[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100463296":3},{"organization":4,"armGroups":7,"interventions":7,"overallOfficials":8,"centralContacts":13,"locations":23,"responsibleParty":36,"collaborators":39,"id":45,"slug":46,"hasResults":47,"nctId":48,"briefTitle":49,"officialTitle":49,"acronym":50,"eligibilityCriteria":51,"healthyVolunteers":47,"sex":52,"minAge":53,"maxAge":54,"enrollmentInfo":55,"targetDuration":7,"studyType":58,"phases":7,"briefSummary":59,"conditions":60,"keywords":7,"overallStatus":62,"whyStopped":7,"lastUpdateSubmitDate":63,"lastUpdatePostDateStruct":64,"startDateStruct":67,"completionDateStruct":69,"leadSponsor":71,"locationsCount":72},{"fullName":5,"class":6},"Johannes Gutenberg University Mainz","OTHER",null,[9],{"name":10,"affiliation":11,"role":12},"Joern Schattenberg, Prof. Dr.","Hepatology","PRINCIPAL_INVESTIGATOR",[14,19],{"name":10,"role":15,"phone":16,"phoneExt":17,"email":18},"CONTACT","+49 (0) 6131 17","6074","joern.schattenberg@unimedizin-mainz.de",{"name":20,"role":15,"phone":16,"phoneExt":21,"email":22},"Belinda Schröder, MSc","6075","belinda.schroeder@unimedizin-mainz.de",[24],{"facility":25,"status":7,"city":26,"state":7,"zip":27,"country":28,"countryCode":29,"cosmosGeoPoint":30,"geoPoint":35,"contacts":7},"University Medical Center of the Johannes Gutenber Univeristy","Mainz","55131","Germany","DE",{"type":31,"coordinates":32},"Point",[33,34],8.28008,49.98185,{"lat":34,"lon":33},{"type":12,"investigatorFullName":37,"investigatorTitle":38,"investigatorAffiliation":5,"oldNameTitle":7,"oldOrganization":7},"Jörn M. Schattenberg","Prof. Dr.",[40,43],{"name":41,"class":42},"Boehringer Ingelheim","INDUSTRY",{"name":44,"class":42},"Nordic Bioscience A\u002FS","100463296","evaluating-the-diagnostic-and-predictive-value-of-non-invasive-tests-nits-on-the-progression-of-chronic-liver-disease-100463296",false,"NCT05312853","Evaluating the Diagnostic and Predictive Value of Non-invasive Tests (NITs) on the Progression of Chronic Liver Disease.","NITOutcomes","Inclusion Criteria:\n\n1. Age ≥18 years\n2. Clinically suspected chronic liver disease based on any of:\n\n   1. Patient with historical liver biopsy providing histological evidence of any liver disease or,\n   2. Patient undergoing liver biopsy for suspected chronic liver disease with biochemical and\u002For radiological findings consistent with liver disease or,\n   3. Patient with clinical and radiological evidence of cirrhosis (in absence of an alternative aetiology)\n   4. Patients with metabolic risk factors predisposing to CLD\n\nExclusion Criteria:\n\n1. Refusal or inability (lack of capacity) to give informed consent.\n2. Age \\\u003C 18 years\n3. Pregnancy\n4. An active malignancy.\n5. Life expectation of \\\u003C 5 years.\n6. Patients not meeting inclusion criteria or judged by the investigator to be unsuitable for inclusion in the study.","ALL","18 Years","99 Years",{"count":56,"type":57},250,"ESTIMATED","OBSERVATIONAL","Primary objective is to study the relevance of non-invasive test (NITs) in predicting disease stage (diagnostic biomarker) and outcome (predictive biomarker) in patients with suspected or established liver disease and cirrhosis.",[61],"Chronic Liver Disease","NOT_YET_RECRUITING","2023-12-27",{"date":65,"type":66},"2024-01-03","ACTUAL",{"date":68,"type":57},"2024-01-15",{"date":70,"type":57},"2034-12-31",{"name":5,"class":6},1]